 | • レポートコード：TPM-B04242 • 出版社/出版日：Transparency Market Research / 2018年3月 • レポート形態：英文、PDF、265ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、化学ルミネセンス免疫検定(CLIA)分析器の世界市場について調べ、化学ルミネセンス免疫検定(CLIA)分析器の世界規模、市場動向、市場環境、製品別分析、用途別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場動向 ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場環境 ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場規模 ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場規模：製品別 ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場規模：用途別 ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場規模：エンドユーザー別 ・化学ルミネセンス免疫検定(CLIA)分析器の世界市場：地域別市場規模・分析 ・化学ルミネセンス免疫検定(CLIA)分析器の北米市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器のアメリカ市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器の中南米市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器のヨーロッパ市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器のアジア市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器の日本市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器の中国市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器のインド市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器の中東市場規模・予測 ・化学ルミネセンス免疫検定(CLIA)分析器のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global chemiluminescence immunoassay (CLIA) analyzers market is mainly driven by the rising demand for ultrasensitive diagnosis of disorders along with improved precision and efficiency, and increasing innovations in the new test offerings. The market is witnessing growing trend of introduction of novel tests with technologically advanced detection precision with reduced incubation time at affordable costs, which is anticipated to steer the global chemiluminescence immunoassay (CLIA) analyzers market growth. Significant adoption rate among professional end-users for newly introduced innovative analyzers is likely to drive the market growth, and value added service assistance of these analyzers in terms of rental service agreements serves as major opportunity for the players operating in the global chemiluminescence immunoassay (CLIA) analyzers market.
The market overview section of the report comprises qualitative analysis of the overall chemiluminescence immunoassay (CLIA) analyzers market considering the factors determining the market dynamics such as drivers, restraints and opportunities, and market attractiveness analysis. In addition, such as market opportunity analysis for the product type, application, and end-user, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The analysis of winning imperatives of top companies has also been provided global chemiluminescence immunoassay (CLIA) analyzers market. The report also covers detailed overview of the global prevalence rates of major diseases in the application areas including, but not limited to endocrine disorders, oncology, infectious diseases, hepatitis & retrovirus, cardiovascular disorders, allergy, autoimmunity, and others. The section technological advancements in the report covers detailed analysis of current technological trends in the global chemiluminescence immunoassay (CLIA) analyzers market. The report also includes a section on healthcare industry overview that deals with the healthcare industry scenario by countries.
The global chemiluminescence immunoassay (CLIA) analyzers market is segmented in terms of product type, application, end-user, and regions. Based on product, the global chemiluminescence immunoassay (CLIA) analyzers market is categorized into analyzers, reagents, and consumables. The segment analyzers is further divided into automated analyzers and semi-automated analyzers. The segment reagents is further bifurcated into enzymatic markers and luminophore markers. On the basis of application, the global chemiluminescence immunoassay (CLIA) analyzers market is classified into endocrine disorders, oncology, infectious diseases, hepatitis & retrovirus, cardiovascular disorders, allergy, autoimmunity, drug discovery & development, and others. Based on end-user segment, the global chemiluminescence immunoassay (CLIA) analyzers market is categorized into hospitals, clinical laboratories, pharmaceutical & biotechnology industries, and others.
Geographically, the global chemiluminescence immunoassay (CLIA) analyzers market has been categorized into five regions namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2015 to 2025, in terms of product type, application, end-user, and countries/sub-regions along with the CAGR (%) for the forecast period 2017 to 2025.
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global chemiluminescence immunoassay (CLIA) analyzers market, in terms of percentage share in 2016 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. Major players having presence in the global chemiluminescence immunoassay (CLIA) analyzers market include Abbott, Siemens Healthineers (Siemens AG), F. Hoffmann-La Roche Ltd., Danaher (Beckman Coulter, Inc.), DiaSorin S.p.A., Sysmex Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics (a part of Carlyle Group), Shenzhen New Industries Biomedical Engineering Co., Ltd., Tosoh Corporation, among others.
The global chemiluminescence immunoassay (CLIA) analyzers market has been segmented as follows:
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Product
Analyzers
Automated
Semi-automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Application
Endocrine Disorders
Oncology
Infectious Diseases
Hepatitis & Retrovirus
Cardiovascular Disorders
Allergy
Autoimmunity
Drug Discovery & Development
Others
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by End-user
Hospitals
Clinical Laboratories
Pharmaceutical & Biotechnology Industries
Others
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, 2015–2025
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Market Outlook
4.6. Disease Prevalence & Incidence Rate globally with key countries
4.7. Technological Advancements
4.8. Top 3 players operating in the market space
4.9. Healthcare Industry Overview
5. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By Product Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Product Type, 2015–2025
5.3.1. Analyzers
5.3.1.1. Automated
5.3.1.2. Semi-automated
5.3.2. Reagents
5.3.2.1. Luminophore Markers
5.3.2.2. Enzymatic Markers
5.3.3. Consumables
5.4. Market Attractiveness By Product Type
6. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Application, 2015–2025
6.3.1. Endocrine Disorders
6.3.2. Oncology
6.3.3. Infectious Diseases
6.3.4. Hepatitis and Retrovirus
6.3.5. Cardiovascular Disorders
6.3.6. Allergy
6.3.7. Autoimmunity
6.3.8. Drug Discovery and Development
6.3.9. Others
6.4. Market Attractiveness By Application
7. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2015–2025
7.3.1. Hospitals
7.3.2. Clinical Laboratories
7.3.3. Pharmaceutical & Biotechnology Industries
7.3.4. Others
7.4. Market Attractiveness By End-user
8. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product Type, 2015–2025
9.2.1. Analyzers
9.2.1.1. Automated
9.2.1.2. Semi-automated
9.2.2. Reagents
9.2.2.1. Luminophore Markers
9.2.2.2. Enzymatic Markers
9.2.3. Consumables
9.3. Market Value Forecast By Application, 2015–2025
9.3.1. Endocrine Disorders
9.3.2. Oncology
9.3.3. Infectious Diseases
9.3.4. Hepatitis and Retrovirus
9.3.5. Cardiovascular Disorders
9.3.6. Allergy
9.3.7. Autoimmunity
9.3.8. Drug Discovery and Development
9.3.9. Others
9.4. Market Value Forecast By End-user, 2015–2025
9.4.1. Hospitals
9.4.2. Clinical Laboratories
9.4.3. Pharmaceutical & Biotechnology Industries
9.4.4. Others
9.5. Market Value Forecast By Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product Type
9.6.2. By Application
9.6.3. By End-user
9.6.4. By Country
10. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2015–2025
10.2.1. Analyzers
10.2.1.1. Automated
10.2.1.2. Semi-automated
10.2.2. Reagents
10.2.2.1. Luminophore Markers
10.2.2.2. Enzymatic Markers
10.2.3. Consumables
10.3. Market Value Forecast By Application, 2015–2025
10.3.1. Endocrine Disorders
10.3.2. Oncology
10.3.3. Infectious Diseases
10.3.4. Hepatitis and Retrovirus
10.3.5. Cardiovascular Disorders
10.3.6. Allergy
10.3.7. Autoimmunity
10.3.8. Drug Discovery and Development
10.3.9. Others
10.4. Market Value Forecast By End-user, 2015–2025
10.4.1. Hospitals
10.4.2. Clinical Laboratories
10.4.3. Pharmaceutical & Biotechnology Industries
10.4.4. Others
10.5. Market Value Forecast By Country/Sub-region, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country/Sub-region
11. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2015–2025
11.2.1. Analyzers
11.2.1.1. Automated
11.2.1.2. Semi-automated
11.2.2. Reagents
11.2.2.1. Luminophore Markers
11.2.2.2. Enzymatic Markers
11.2.3. Consumables
11.3. Market Value Forecast By Application, 2015–2025
11.3.1. Endocrine Disorders
11.3.2. Oncology
11.3.3. Infectious Diseases
11.3.4. Hepatitis and Retrovirus
11.3.5. Cardiovascular Disorders
11.3.6. Allergy
11.3.7. Autoimmunity
11.3.8. Drug Discovery and Development
11.3.9. Others
11.4. Market Value Forecast By End-user, 2015–2025
11.4.1. Hospitals
11.4.2. Clinical Laboratories
11.4.3. Pharmaceutical & Biotechnology Industries
11.4.4. Others
11.5. Market Value Forecast By Country/Sub-region, 2015–2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2015–2025
12.2.1. Analyzers
12.2.1.1. Automated
12.2.1.2. Semi-automated
12.2.2. Reagents
12.2.2.1. Luminophore Markers
12.2.2.2. Enzymatic Markers
12.2.3. Consumables
12.3. Market Value Forecast By Application, 2015–2025
12.3.1. Endocrine Disorders
12.3.2. Oncology
12.3.3. Infectious Diseases
12.3.4. Hepatitis and Retrovirus
12.3.5. Cardiovascular Disorders
12.3.6. Allergy
12.3.7. Autoimmunity
12.3.8. Drug Discovery and Development
12.3.9. Others
12.4. Market Value Forecast By End-user, 2015–2025
12.4.1. Hospitals
12.4.2. Clinical Laboratories
12.4.3. Pharmaceutical & Biotechnology Industries
12.4.4. Others
12.5. Market Value Forecast By Country/Sub-region, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2015–2025
13.2.1. Analyzers
13.2.1.1. Automated
13.2.1.2. Semi-automated
13.2.2. Reagents
13.2.2.1. Luminophore Markers
13.2.2.2. Enzymatic Markers
13.2.3. Consumables
13.3. Market Value Forecast By Application, 2015–2025
13.3.1. Endocrine Disorders
13.3.2. Oncology
13.3.3. Infectious Diseases
13.3.4. Hepatitis and Retrovirus
13.3.5. Cardiovascular Disorders
13.3.6. Allergy
13.3.7. Autoimmunity
13.3.8. Drug Discovery and Development
13.3.9. Others
13.4. Market Value Forecast By End-user, 2015–2025
13.4.1. Hospitals
13.4.2. Clinical Laboratories
13.4.3. Pharmaceutical & Biotechnology Industries
13.4.4. Others
13.5. Market Value Forecast By Country/Sub-region, 2015–2025
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Israel
13.5.4. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2016)
14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. Abbott
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.1.2 Financial Overview
14.3.1.3 Product Portfolio
14.3.1.4 SWOT Analysis
14.3.1.5 Strategic Overview
14.3.2. F. Hoffmann-La Roche Ltd
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.2.2 Financial Overview
14.3.2.3 Product Portfolio
14.3.2.4 SWOT Analysis
14.3.2.5 Strategic Overview
14.3.3. Siemens Healthcare GmbH (Siemens AG)
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.3.2 Financial Overview
14.3.3.3 Product Portfolio
14.3.3.4 SWOT Analysis
14.3.3.5 Strategic Overview
14.3.4. Danaher (Beckman Coulter, Inc.)
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.4.2 Financial Overview
14.3.4.3 Product Portfolio
14.3.4.4 SWOT Analysis
14.3.4.5 Strategic Overview
14.3.5. DiaSorin S.p.A.
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.5.2 Financial Overview
14.3.5.3 Product Portfolio
14.3.5.4 SWOT Analysis
14.3.5.5 Strategic Overview
14.3.6. Ortho Clinical Diagnostics (Part of Carlyle Group)
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.6.2 Financial Overview
14.3.6.3 Product Portfolio
14.3.6.4 SWOT Analysis
14.3.6.5 Strategic Overview
14.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.7.2 Financial Overview
14.3.7.3 Product Portfolio
14.3.7.4 SWOT Analysis
14.3.7.5 Strategic Overview
14.3.8. Sysmex Corporation
14.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.8.2 Financial Overview
14.3.8.3 Product Portfolio
14.3.8.4 SWOT Analysis
14.3.8.5 Strategic Overview
14.3.9. Randox Laboratories Ltd.
14.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.9.2 Financial Overview
14.3.9.3 Product Portfolio
14.3.9.4 SWOT Analysis
14.3.9.5 Strategic Overview
14.3.10. Tosoh Corporation
14.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
14.3.10.2 Financial Overview
14.3.10.3 Product Portfolio
14.3.10.4 SWOT Analysis
14.3.10.5 Strategic Overview
15. Key Take Aways
*Note: Financial details for companies that do not report this information in public domain might not be captured”
Table 01: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 03: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2015–2025
Table 04: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 05: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 06: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 07: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 08: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 09: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 10: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2015–2025
Table 11: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 12: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 15: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 16: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2015–2025
Table 17: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 18: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 19: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 20: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 21: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 22: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2015–2025
Table 23: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 26: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 27: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 28: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2015–2025
Table 29: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 30: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 31: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 32: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 33: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 34: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2015–2025
Table 35: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 36: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2015–2025